These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1512830)

  • 1. Distribution of 486P 3/12 antigen, ABO(H) blood group antigen and T antigen in cystectomy specimens from patients with stage T2 transitional cell carcinoma of the bladder.
    Heinzer H; Huland E; Mönk M; Huland H
    J Urol; 1992 Sep; 148(3):802-5. PubMed ID: 1512830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
    Byrne RR; Shariat SF; Brown R; Kattan MW; Morton RA JR; Wheeler TM; Lerner SP
    J Urol; 2001 May; 165(5):1473-9. PubMed ID: 11342899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer.
    Vafier JA; Javadpour N; Worsham GF; O'Connell KJ
    Urology; 1984 Apr; 23(4):348-51. PubMed ID: 6369713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monoclonal antibodies (MIB 1, PC 10, 486p and p53) as prognostic factors for recurrent urothelial carcinoma of the urinary bladder].
    Hake R; Vorreuther R; Borchmann P; Lukowsky S; Thiele J; Fischer R
    Verh Dtsch Ges Pathol; 1993; 77():236-40. PubMed ID: 7511288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood group H antigen in transitional carcinoma of the urinary bladder.
    Tichý M; Tichá V; Jansa P; Student V; Vanák J
    Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prediction of invasive potential in superficial transitional cell carcinoma of the bladder.
    Finan PJ; Anderson JR; Doyle PT; Lennox ES; Bleehen NM
    Br J Urol; 1982 Dec; 54(6):720-5. PubMed ID: 6758916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.
    Huland E; Huland H; Meier T; Baricordi O; Fradet Y; Grossman HB; Hodges GM; Messing EM; Schmitz-Draeger BJ
    J Urol; 1991 Dec; 146(6):1631-6. PubMed ID: 1719252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder.
    Nakatsu H; Kobayashi I; Onishi Y; Igawa M; Ito H; Tahara E; Nihira H
    J Urol; 1984 Feb; 131(2):252-7. PubMed ID: 6366250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
    Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
    J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of blood group surface antigens of urinary bladder tumours using monoclonal antibodies with the avidin-biotin complex technique.
    Tan LB; Chiang C; Huang CH; Lin LM
    Int Urol Nephrol; 1992; 24(3):255-64. PubMed ID: 1399382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis.
    Nguyen PL; Swanson PE; Jaszcz W; Aeppli DM; Zhang G; Singleton TP; Ward S; Dykoski D; Harvey J; Niehans GA
    Am J Clin Pathol; 1994 Feb; 101(2):166-76. PubMed ID: 7906919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO blood groups and their relationship to transitional cell carcinoma of the urinary bladder in 30 Jordanian patients.
    Murshidi MS
    Acta Urol Belg; 1988; 56(4):517-22. PubMed ID: 3207084
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoclonal antibodies to detect A, B and H blood group isoantigens in superficial transitional cell carcinoma of the bladder: a means of predicting invasive recurrences.
    Stephenson TJ; Williams JL; Gelsthorpe K
    Br J Urol; 1985 Apr; 57(2):148-53. PubMed ID: 3886066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mapping of histology and cell proliferation in human bladder cancer: an immunohistochemical study.
    Igawa M; Urakami S; Shirakawa H; Shiina H; Ishibe T; Usui T; Moriyama H
    Hiroshima J Med Sci; 1995 Dec; 44(4):93-7. PubMed ID: 8857231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of urine cytology with ABO(H) antigenicity in transitional cell carcinoma of the bladder.
    Das G; Glashan RW
    J Clin Pathol; 1988 May; 41(5):538-9. PubMed ID: 3384984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of ABH(O) blood group antigen expression in intraepithelial dysplastic lesions to clinicopathologic properties of associated transitional cell carcinoma of the bladder.
    Yamada T; Fukui I; Kobayashi T; Sekine H; Yokogawa M; Yamada T; Oshima H
    Cancer; 1991 Mar; 67(6):1661-6. PubMed ID: 2001555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated antigens in normal mucosa of patients with superficial transitional cell carcinoma of the bladder.
    Lee E; Schwaibold H; Fradet Y; Huland E; Huland H
    J Urol; 1997 Mar; 157(3):1070-3. PubMed ID: 9072545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of transitional cell carcinoma in bladder by intravesical injection of monoclonal antibodies.
    Chopin DK; deKernion JB
    Urol Res; 1986; 14(3):145-8. PubMed ID: 3529570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO(H) antigens and beta-2 microglobulin in transitional cell carcinoma. Predictors of response to intravesical bacillus Calmette-Guerin.
    Sanders H; McCue P; Graham SD
    Cancer; 1991 Jun; 67(12):3024-8. PubMed ID: 1710534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of A,B and H blood group antigens in urothelial carcinoma of the urinary bladder].
    Tichý M; Tichá V; Jansa P; Student V; Vanák J
    Cesk Patol; 1991 Mar; 27(1-2):13-9. PubMed ID: 1893425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.